BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND GNA11, GNA-11, 2767, ENSG00000088256 AND Diagnosis
9 results:

  • 1. Development and Validation of a Nomogram Based on Multimodality Ultrasonography Images for Differentiating Malignant from Benign American College of Radiology Thyroid Imaging, Reporting and Data System (TI-RADS) 3-5 Thyroid Nodules.
    Pang L; Yang X; Zhang P; Ding L; Yuan J; Liu H; Liu J; Gong X; Yu M; Luo W
    Ultrasound Med Biol; 2024 Apr; 50(4):557-563. PubMed ID: 38262884
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
    Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
    J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma.
    Brown ZJ; Labiner HE; Shen C; Ejaz A; Pawlik TM; Cloyd JM
    J Surg Oncol; 2022 Feb; 125(2):185-193. PubMed ID: 34599756
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Driver pattern identification over the gene co-expression of drug response in ovarian cancer by integrating high throughput genomics data.
    Lu X; Lu J; Liao B; Li X; Qian X; Li K
    Sci Rep; 2017 Nov; 7(1):16188. PubMed ID: 29170526
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.
    Corno C; Gatti L; Arrighetti N; Carenini N; Zaffaroni N; Lanzi C; Perego P
    Biochem Pharmacol; 2017 Jul; 136():40-50. PubMed ID: 28404378
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinicopathological correlates of hyperparathyroidism.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Pancreatic endocrine tumors].
    Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
    Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Primary hyperaldosteronism: our experience with 34 patients].
    Arganini M; Pascucci S; Matteo Cecchini G; Spinelli C; Miccoli P
    Ann Ital Chir; 1990; 61(6):603-6. PubMed ID: 2100107
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.